Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Apiter is a Uruguayan pharmaceutical company specializing in the research, development, and manufacturing of propolis-based products and other natural extracts. Founded in 1979, the company has established itself as a global leader in propolis technology, utilizing standardized extraction processes to produce high-quality therapeutic agents. Apiter operates state-of-the-art manufacturing facilities that comply with GMP standards, offering a range of finished products including sprays, tablets, and topical treatments. In addition to its proprietary line, the company provides contract manufacturing services for the pharmaceutical and nutraceutical industries. Its research focus extends to the antimicrobial, anti-inflammatory, and antioxidant properties of bee-derived substances. The company exports its products to various regions, including North America, Europe, and Asia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Apiter Laboratories.